Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for United Therapeutics (UTHR) over the last 16 years, with Q3 2025 value amounting to 0.17%.

  • United Therapeutics' Return on Invested Capital rose 100.0% to 0.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.16% for FY2024, which is 0.0% changed from last year.
  • United Therapeutics' Return on Invested Capital amounted to 0.17% in Q3 2025, which was up 100.0% from 0.16% recorded in Q2 2025.
  • United Therapeutics' Return on Invested Capital's 5-year high stood at 0.18% during Q1 2022, with a 5-year trough of 0.09% in Q1 2021.
  • Over the past 5 years, United Therapeutics' median Return on Invested Capital value was 0.16% (recorded in 2024), while the average stood at 0.15%.
  • Per our database at Business Quant, United Therapeutics' Return on Invested Capital crashed by -800bps in 2021 and then surged by 900bps in 2022.
  • United Therapeutics' Return on Invested Capital (Quarter) stood at 0.11% in 2021, then skyrocketed by 40bps to 0.16% in 2022, then dropped by -8bps to 0.15% in 2023, then grew by 9bps to 0.16% in 2024, then grew by 3bps to 0.17% in 2025.
  • Its Return on Invested Capital stands at 0.17% for Q3 2025, versus 0.16% for Q2 2025 and 0.16% for Q1 2025.